Gene Therapy Market 2018: A Growing Pipeline and Approval of CAR-T Cell Therapies Reflect Increasing Commercial … – Business Wire (press release)
|
Gene Therapy Market 2018: A Growing Pipeline and Approval of CAR-T Cell Therapies Reflect Increasing Commercial …
Business Wire (press release) This gene therapies report discusses all gene therapies, including not only those which involve genetic modification, but also RNAi, CART cell and aptamerbased therapies. In 2017 alone, the marketing approvals of Kymriah, Yescarta and Luxturna added to … |
